Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing LOUISVILLE, KY — Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody tests for COVID-19. Since the emergence of COVID-19 outbreaks in January, Meridian has supported molecular diagnostic companies with critical master mixes and enzymes for their COVID-19 Molecular Diagnostics tests. To meet the massive need for […]
IDT’s new panel includes the Iowa Black-ZEN quencher probe technology recently approved for use in existing CDC EUA testing protocol Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced a significant expansion of its coronavirus product line with the addition of primer-probe kits equivalent to the primer and probe ratios described in the WHO-Charité/Berlin (“WHO”) […]
Middleton, WI – Gilson is pleased to announce a new industrial-scale centrifugal partition chromatography (CPC) system: VERITY® CPC Process . This is the solution for customers requesting larger capacity CPC systems with a high return on investment. The new system is easy-to-use and has broad applicability, namely in the natural extract, cosmetics, and pharmaceutical industries. With the […]
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion SAN ANTONIO, TX – Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes from StemBioSys. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or […]
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes Supports global efforts to develop therapeutics, diagnostic assay components and vaccines to combat the COVID-19 Coronavirus pandemic Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene […]
MGI has announced a major upgrade for DNBSEQ-G50 with improvements to flexibility, turnaround time and performance. The original FC (Flow Cell) with 300M total reads is upgraded to FCL (Flow Cell Large) with 500M total reads, and a new FCS (Flow Cell Small) has been released with total reads of 100M. In addition, a longer […]
Carlsbad, CA – On February 26, 2020, Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia (COVID-19). The full suite of antibodies is now available for research as well as commercial applications. “The discovery and expression of a full human antibody against the COVID-19 virus is […]
Pioneering synthetic DNA company releases a wide range of antigen panels, synthetic DNA parts, and vaccine scaffolds to expedite vaccine development, drug discovery, and diagnostics SAN DIEGO, California — Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXo ” 3200 system, today announced a newly developed […]
Synthesizing 768 oligos just got faster with Dr. Oligo 768XLc The Dr. Oligo 768XLc high throughput oligo synthesizer is Biolyticʻs fastest synthesizer yet FREMONT, California – Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
